Showing results (121-130 of 409) with videos related to

Sort By:
Pageof 41
BMC Neurology|October 21, 2010
Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patientsLaetitia Horzinski, Liraz Kantor, Aurélia Huyghe, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 25, 2006
Fabry disease and vascular risk factors: future strategies for patient-based studies and the knockout murine modelDavid F Moore, Monique P Gelderman, Steven R Fuhrmann, et al.
Neurology. Genetics|July 28, 2017
Functionally pathogenic EARS2 variants in vitro may not manifest a phenotype in vivoNathan McNeill, Alessia Nasca, Aurelio Reyes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 24, 2015
Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosisKatrin Weier, Christine Till, Vladimir Fonov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 11, 2015
Evaluation of fall Sun Exposure Score in predicting vitamin D status in young Canadian adults, and the influence of ancestryLauren Sham, E Ann Yeh, Sandra Magalhaes, et al.
Plos One|January 6, 2016
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple SclerosisNadine Akbar, Antonio Giorgio, Christine Till, et al.
Archives of Disease in Childhood|September 3, 2010
Nocturnal hypoventilation: predictors and outcomes in childhood progressive neuromuscular diseaseSherri L Katz, Isabelle Gaboury, Krista Keilty, et al.
Journal of the Neurological Sciences|March 23, 2016
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective studyLauren B Krupp, Daniela Pohl, Angelo Ghezzi, et al.
Orphanet Journal of Rare Diseases|November 27, 2014
Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up studyRaphael Schiffmann, Gregory M Pastores, Yeong-Hau H Lien, et al.
Pageof 41